02.12.2019
- Clariant has formed a strategic partnership with Plant Advanced Technologies (PAT), which will see the Swiss group take a stake of around 10% in the French plant biotech company...
Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion...
20.11.2019
- Martin Shkreli, former CEO of the Retrophin hedge fund and Turing Pharmaceuticals, who was convicted of securities fraud and conspiracy in 2017, appears to have run out of options...
20.11.2019
- The US Federal Trade Commission has approved Bristol-Myers Squibb’s $74 billion takeover of biotech Celgene by a vote of 3 to 2. The biggest merger in the history of the global...
13.11.2019
- Marc Funk resigned as CEO of Lonza on Nov. 12, citing personal reasons, after only eight months at the helm of the Swiss CDMO. The news took most observers and investors by...
04.11.2019
- US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...
With the cost pressures and time to market challenges that the health care industry faces, pharmaceutical and biotech companies must figure out ways to increase...
30.10.2019
- Japan’s Takeda Pharmaceutical has bought an exclusive global license to an investigational therapy for celiac disease from US biotech Cour Pharmaeuticals. Takeda will develop and...
23.10.2019
- GlaxoSmithKline (GSK) is selling its travel vaccines Rabipur and Encepur to Danish biotech Bavarian Nordic. The vaccines were acquired from Novartis in 2015. Rabipur is for...
14.10.2019
- Major UK drugmaker GlaxoSmithKline (GSK) has announced a five-year collaboration with US biotech Lyell Immunopharma to develop new technologies to improve cell therapies for cancer...
